SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing significant price volatility as traders speculate on the pending results of the Phase 3 REGAL trial, with intense community debate occurring between those anticipating a major breakthrough buyout and those concerned about the lack of recent news and the risk of a binary outcome. Sentiment is heavily polarized, with many retail participants dismissing the decline as market manipulation while others express concern over the extended trial timeline.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as investors weigh aggressive AI infrastructure spending and broader market volatility against Chairman Larry Ellison's unexpected cancellation of a planned $7.5 billion stock sale. While some traders view the canceled sale as a bullish sign of management's confidence, others remain cautious due to the company's high debt levels and the recent industry-wide debate regarding the pace of AI development.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending amid a sharp sell-off triggered by market-wide volatility and renewed debates over the pace of AI development. Traders are debating whether to buy the dip or if the sector is facing a structural correction, with many citing concerns over AI regulation and potential slowing of infrastructure capital expenditure.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending upward amid strong sentiment in the AI infrastructure sector, fueled by excitement surrounding recent generative AI model releases and reports of heavy compute demand. While some traders express caution over high debt levels and insider selling, others remain bullish on the company's multi-year contract backlog and its role as a key provider of specialized GPU infrastructure.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology shares are trending as traders debate whether industry-wide calls to slow the pace of AI development will impact long-term memory demand or if the fears are merely temporary market noise. While some investors fear a cooling of the AI infrastructure boom, many maintain that structural demand for memory remains robust regardless of model release pacing.

The Elmet Group Co. engages in the provision of precision-engineered components. The firm offers its products and solutions to aerospace, defense, industrial, medical, semiconductor, electronics, energy industry and also the government. It operates through the Critical Materials Components and Engineered Microwave Products business divisions. The company was founded on September 13, 2024 and is headquartered in Portland, ME.

Elmet Group Co. (The)

The Elmet Group

ELMT is trending following a significant U.S. government investment and a multi-billion dollar defense contract to bolster domestic tungsten supply chains, though some traders have raised concerns about potential future dilution from warrants. Market sentiment remains divided between bulls focused on the company's strategic defense role and skeptics warning of a possible pump-and-dump scheme.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble shares are experiencing volatility following reports that Anthropic is the unnamed customer behind the company's recently disclosed $13.7 billion compute infrastructure deal. While some traders view the partnership as a major long-term catalyst for the firm's AI cloud expansion, others remain cautious due to broader market pressures and uncertainty regarding the data center's financing.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is trending as investors react to increased volatility in memory stocks driven by concerns over geopolitical tensions, potential trade tariffs, and sector-wide selling. The conversation is fragmented, with traders debating whether this pull-back represents a healthy consolidation amid strong fundamental demand for AI infrastructure or the start of a broader cyclical downturn.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are trending as traders digest a broader sell-off in the semiconductor sector, fueled by a high-profile industry call for a slowdown in the pace of frontier AI development. While some investors fear this shift could temper infrastructure demand, many maintain a bullish outlook, dismissing the decline as a temporary reaction to media-driven sentiment.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending following the announcement of positive topline results from the Phase 3 Panorama study of its DT120 ODT treatment for generalized anxiety disorder. While some traders celebrate the milestone as a key clinical success, others express skepticism regarding the company's valuation and the long-term commercial scalability of the required clinical monitoring.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$UBER $UBER — a little more context on my chart:

Since March, price has been moving through a broad consolidation. The key sequence for me was:

Liquidity sweep below the prior lows → immediate Higher High → retracement into the 61.8–78.6% OTE zone → buyers stepping back in.

Zooming out makes it even more interesting: the recent major low is what I label Wave 4 of the larger Elliott structure, and it remained above the Wave 1 high from February 2021.

That keeps the Elliott structure intact, since Wave 4 should not overlap Wave 1 territory.

So far, the larger thesis remains valid and my projected Wave 5 targets are still on the table.

The coming week — or coming weeks — could be decisive.

Liquidity sweep. OTE reaction. Elliott structure intact. Now we need confirmation.

Nicolas Huet

Brian P.

StockTwits For Android 

Uber Technologies Inc

Baxter

 — a little more context on my chart:

Since March, price has been moving through a broad consolidation. The key sequence for me was:

Liquidity sweep below the prior lows → immediate Higher High → retracement into the 61.8–78.6% OTE zone → buyers stepping back in.

Zooming out makes it even more interesting: the recent major low is what I label Wave 4 of the larger Elliott structure, and it remained above the Wave 1 high from February 2021.

That keeps the Elliott structure intact, since Wave 4 should not overlap Wave 1 territory.

So far, the larger thesis remains valid and my projected Wave 5 targets are still on the table.

The coming week — or coming weeks — could be decisive.

Liquidity sweep. OTE reaction. Elliott structure intact. Now we need confirmation.

@Aktienbax so what would be your confirmation in the coming week ? And your first price target ?

StockTwits Web

 so what would be your confirmation in the coming week ? And your first price target ?

@Ramoloss94 I wouldn’t give a price target for next week — that’s simply not how I approach this.

I’ve actually been actively building my $UBER position since this basing process started around March, primarily because of the business, fundamentals and improving numbers — not because of the chart.

What has changed now is that the chart is starting to support the fundamental thesis as well.

For confirmation, I’d like to see the current bullish structure continue, with buyers defending the OTE area and price reclaiming the recent resistance / swing-high zone.

Regarding targets: based on my larger Elliott Wave + Fibonacci projection, my first technical upside area is around $84.8.

Beyond that, my calculated Wave 5 projection zones are roughly:

$105–116
$129–130
$147
and, in an extended scenario, around $170.

Those are not “next week” targets — they are longer-term technical projection zones if my Elliott Wave count continues to play out.

Fundamentals first.

 I wouldn’t give a price target for next week — that’s simply not how I approach this.

I’ve actually been actively building my 

 position since this basing process started around March, primarily because of the business, fundamentals and improving numbers — not because of the chart.

What has changed now is that the chart is starting to support the fundamental thesis as well.

For confirmation, I’d like to see the current bullish structure continue, with buyers defending the OTE area and price reclaiming the recent resistance / swing-high zone.

Regarding targets: based on my larger Elliott Wave + Fibonacci projection, my first technical upside area is around $84.8.

Beyond that, my calculated Wave 5 projection zones are roughly:

$105–116
$129–130
$147
and, in an extended scenario, around $170.

Those are not “next week” targets — they are longer-term technical projection zones if my Elliott Wave count continues to play out.

Fundamentals first.

@Aktienbax i understand better thanks a lot for your explanation ! What would be your invalidation scenario ? A daily close below the OTE ?

 i understand better thanks a lot for your explanation ! What would be your invalidation scenario ? A daily close below the OTE ?